Focus, Health Care, and Manufacturing

Rose Technologies expanding

Additional space will allow anticipated sales growth of 15 to 20 percent a year.

October 3, 2014
| By Pete Daly |
Print
Text Size:
A A
Rose Technologies
Craig Finkel, director of sales and marketing at Rose Technologies, says the two buildings will be attached to increase the production area. Courtesy Rose Technologies

Rose Technologies, a custom medical device manufacturer that works under contract for major players in the medical device industry in the United States and Europe, is investing in new construction at its Front Street plant in Grand Rapids, which a spokesperson says will “continue to allow us to grow 15 to 20 percent a year.”

Craig Finkel, director of sales and marketing at Rose, said the company acquired a second building a few years ago on the north side of its original facility at 1440 Front St. NW. He said the three principals — Todd Grimm, Steve Gronsman and Eric Vroegop — bought the second building for the purpose of future expansion.

The $300,000 project being managed by Triangle Construction is an addition that connects the two buildings, giving Rose an additional 15,000 square feet.

The attachment of the second building “allows us to make some significant changes in the main building and to increase production areas significantly,” said Finkel.

He also noted the current construction is Phase 1, with more areas between the two buildings to be built out in the future.

Rose Technologies manufactures wire-reinforced cannulae — flexible silicon tubes used in cardiovascular surgery — plus catheters for surgical use. Much of what it produces are disposable surgical devices.

“We have become and continue to grow this part of the business as a single source provider, from development of a new device or improved current device all the way through assembly, packaging, sterilization and shipping to the OEM,” said Finkel.

Rose Technologies now employs more than 50. Annual sales revenue for the privately held company is not publicized.

In late 2007, a Business Journal article noted that employment at the company was about 21. Rose Technologies was heavily involved in designing and building manufacturing equipment for a medical device research and development company in Ann Arbor, specifically a temporary artificial “lung-assist” device for patients undergoing a lung transplant or recovering from a lung injury.

In early 2013, Rose successfully completed the rigorous process for advanced ISO certification that allowed it to add sterilization and packaging to its manufacturing capability, greatly increasing its sales potential.

The major medical device project Rose has underway now is related to nuclear medicine although Finkel said he was not at liberty to identify the customer or go into details of the device, due to contract stipulations.

“If I named our top 10 customers, you would recognize many of them as major medical device manufacturers,” he said.

The company’s growth “is split pretty much between continued growth of current customers, and the success of acquiring new customers with new therapies and new devices,” said Finkel.

The company was founded in 1998 by Grimm, who is president of Rose Technologies. He named the business after his grandmother’s first name, and soon was joined in the business by Gronsman and Vroegop. Gronsman is the firm’s director of manufacturing engineering, and Vroegop is director of operations.

All three men are engineers and had been employed at DLP Inc., a medical device company, when it was acquired by Medtronic, which later moved DLP out of state.

Recent Articles by Pete Daly

Editor's Picks

Comments powered by Disqus